Demonstrators gather in front of the Supreme Court as the Court hears oral arguments in FDA v. Alliance for Hippocratic Medicine on March 26, 2024. The case challenges the 20-plus-year legal authorization by the FDA of mifepristone, a commonly used abortion medication. (Madelyn Amos) |
BY ROXANNE SZAL | The Supreme Court heard oral arguments on Tuesday in the first abortion-related case since the Court overturned Roe v. Wade—this time, over access to the abortion pill mifepristone.
Ahead of Tuesday, feminists and reproductive rights advocates warned that an adverse decision from the same Court that overturned the constitutional right to abortion would impact abortion access nationwide.
During oral arguments, the DOJ and Danco emphasized the safety of mifepristone, but also focused much of their arguments on standing—whether or not the anti-abortion doctors and dentists challenging the FDA's regulations have sufficient legal grounds to bring the lawsuit. If the Court agrees—deciding the plaintiffs do not have standing to sue—it could dismiss the case altogether. But feminists know: "The Court does not always side with what is best for our communities."
(Click here to read more) |